Clinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative...
FILE PHOTO: A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration
The Federal University of Sao Paulo, which is running the trials, said in a statement that 4,600 of the planned 5,000 volunteers have been vaccinated in Brazil without any of them reporting any serious health issues. AstraZeneca paused global trials temporarily last week after an unexplained illness in a participant in Britain.
Phase III clinical trials of Russia’s Sputnik V vaccine against COVID-19 will be conducted in the Brazilian states of Bahia and Parana, which has plans to produce the vaccine for Brazil and other Latin American countries.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid-19 Batters Brazil, but Its Leader Is More Popular Than EverSupport for Brazilian President Jair Bolsonaro has risen as his government hands out cash to the poor to help them ride out the Covid-19 economic storm
Weiterlesen »
Burned jaguars, fire tornadoes: Blazes in Brazil wetland deliver climate warningA fire has been burning since mid-July in the remote wetlands of west-central Brazil, leaving in its wake a vast charred desolation bigger than New York City.
Weiterlesen »
Brazil registers more than 800 coronavirus deaths – latest updatesCoronavirus pandemic kills over 924,000 people and infects more than 28.9 million worldwide. Other Covid-19 updates: 🇧🇷Brazil registers 814 deaths, 33,523 cases 🇿🇦South Africa reports 1,816 cases, 49 deaths 🇺🇸Missouri tops 100,000 cases Read more:
Weiterlesen »
AstraZeneca's COVID-19 vaccine trial in the U.S. remains halted: reportU.S. trials of AstraZeneca Plc.'s undefined and Oxford University COVID-19 vaccine candidate will be on hold until at least midweek, pending a Federal Drug...
Weiterlesen »
Vaccine maker got $1 billion from taxpayers. Now it's boosting drug pricesOne of the world’s largest drug companies has been aggressively raising prices even as it received hundreds of millions of dollars of U.S. government aid to develop a COVID-19 vaccine.
Weiterlesen »
Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sourcesAstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
Weiterlesen »